Amgen and AstraZeneca has announced that AMAGINE-3(TM), a pivotal, multi-arm Phase 3 trial evaluating two doses of brodalumab in more than 1,800 patients with moderate-to-severe plaque psoriasis...
The costs associated with skin cancer increased five times as fast as treatments for other cancers between 2002 and 2011, according to a CDC study published online in the American Journal of...
Researchers at the U. of Granada have developed an innovative technique which facilitates the preventive identification of potential damage in the skin of a patient before he or she is submitted to...
A tiny fraction of adverse events occurred after dermatologists performed more than 20,000 noninvasive and minimally invasive cosmetic procedures, according to a study published online by JAMA...
An antibody abundant in mice and previously thought to offer poor assistance in fighting against infection may actually play a key role in keeping immune responses in check and preventing more...
Syneron Medical Ltd., a leading global aesthetic device company, has announced the US Food and Drug Administration (FDA) clearance of the new PicoWay picosecond device.
Innovative research published in the latest edition of the British Journal of Dermatology reveals the causes behind the emotional distress experienced by people with psoriasis.
Leading manufacturer of scalp cooling equipment Paxman Coolers is to fund research into the science behind hair loss during chemotherapy treatmentA patient wears a scalp cooler for 30 minutes...
The itch-scratch cycle has puzzled scientists - why does scratching both relieve and exacerbate itching? Now, a new mouse study has identified how serotonin influences the cycle.